Frontlight ResearchEarly access
CompletedNo phase
Individualized Study of Refeeding to Optimize iNpatient Gains
Key facts
- Who runs it
- University of California, San Francisco
- Where
- Palo Alto and San Francisco, United StatesSee the 2 sites
- Trial code
- Status
- Completed
- People taking part
- 77 people enrolled
- Started
- 12 Oct 2021
- Ended
- 3 Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Individualized Caloric Refeeding (ICR)
- Higher Calorie Refeeding (HCR)
- Record updated
- 25 September 2026
Who can take part
- Age
- 12 years to 24 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- Age 12-24 yrs
- Meets Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for AAN
- Hospitalized with medical instability, as defined by:; night time heart rate (HR) <45 bpm,; systolic blood pressure (SBP) <90 mmHg,; temperature <35.6° C,; orthostatic Δ HR >35 bpm, or; orthostatic Δ SBP >20 mmHg
Who cannot take part
- Hospital admissions for refeeding in the prior 6 mo
- Chronic disease (e.g. immune, renal disease)
- Bulimia nervosa
- Current pregnancy
- Acute/active suicidality or psychosis
Where in United States
- Stanford University Lucille Packard Children's HospitalPalo Alto, United States
- University of California San Francisco-Benioff Children's HospitalSan Francisco, United States
About the trial
What the trial wants to find out
The primary purpose of the trial is to compare the efficacy and safety of Individualized Caloric Refeeding (ICR) to the new standard of care, Higher Calorie Refeeding (HCR), in hospitalized patients with atypical anorexia nervosa (AAN), and clinical remission over one year of follow-up.
The 2 groups in the trial
- Individualized Caloric Refeeding (ICR)Treatment being tested
Starting 50 kcal/kg/d, increasing by 200 kcal/d to goal
- Higher Calorie Refeeding (HCR)Existing treatment, for comparison
Starting 2000 kcal/d, increasing by 200 kcal/d to goal
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Renewal of the Multi-center Randomized Controlled Trial of Refeeding in Anorexia Nervosa
- Record updated
- 25 September 2026